GGrantIndex
← Search

Development of Monoclonal Antibody-mediated Interventions to Combat Malaria

$300,000N43FY2022AINIH

Antagen Pharmaceuticals, Inc., Boston MA

Investigators

Abstract

To support proof of concept studies for the development of a monoclonal antibody to combat malaria.

View original record on NIH RePORTER →